Farooq Javeria, Khaliq Sheikh Abdul, Ghuman Faiza, Shaikh Javeria, Azhar Iqbal
Faculty of Health Sciences, Iqra University, Karachi, Pakistan.
Department of Pharmacy Practice and Pharmaceutics, Faculty of Pharmacy, Hamdard University, Karachi 74600, Pakistan.
Evid Based Complement Alternat Med. 2022 Aug 29;2022:4699414. doi: 10.1155/2022/4699414. eCollection 2022.
The cross-sectional survey was conducted; primary data were collected from asthmatic patients in different hospitals and clinics of allopathic, homeopathic, and herbal practitioners in Karachi, Pakistan. The study duration was from January 2020 to December 2020. Asthmatic patients aged over 13 years were selected for the study. A written informed consent was taken from the patients before the interview. Collected data were analyzed by the Statistical Package of Social Sciences (SPSS) 22.
Among 255 asthmatic patients; 51.4% ( = 131) were male and 48.6% ( = 124) were female. For control of acute attacks of asthma 88.2% ( = 0.0001) of patients significantly preferred allopathic treatment while 6.3% ( = 0.008) used homeopathic treatment and 5.5% chose herbal treatment. For maintenance of asthma, 78.8% ( = 0.0001) patients used allopathic treatment while 12.4% ( = 0.0001) homeopathic and 8.8% ( = 0.0001) patients used herbal treatment. About 63.4% ( = 0.0001) of the asthmatic patients used short-acting -2 agonists for managing acute asthmatic episodes while long-acting -2 agonists ( = 0.0001) and inhaled corticosteroids ( = 0.0001) were found to be the preferred medicines for maintenance therapy. Effectiveness of treatment ( = 0.004) and cost effectiveness ( = 0.0001) significantly act as contributing factors for the selection of the treatment. The majority of the patients were satisfied with their chosen treatments for control of asthmatic symptoms.
Most asthmatic patients preferred allopathic treatment for the management of acute episodes and control of asthmatic symptoms. It was found that the major factors for selecting a specific treatment include effectiveness, cost, and minimal side effects.
开展了横断面调查;从巴基斯坦卡拉奇的不同医院以及对抗疗法、顺势疗法和草药疗法从业者的诊所中的哮喘患者收集原始数据。研究持续时间为2020年1月至2020年12月。选择年龄超过13岁的哮喘患者进行研究。在访谈前获得了患者的书面知情同意书。收集的数据采用社会科学统计软件包(SPSS)22进行分析。
在255名哮喘患者中,51.4%(n = 131)为男性,48.6%(n = 124)为女性。对于哮喘急性发作的控制,88.2%(p = 0.0001)的患者明显更倾向于对抗疗法治疗,而6.3%(p = 0.008)使用顺势疗法治疗,5.5%选择草药治疗。对于哮喘的维持治疗,78.8%(p = 0.0001)的患者使用对抗疗法治疗,12.4%(p = 0.0001)使用顺势疗法,8.8%(p = 0.0001)的患者使用草药治疗。约63.4%(p = 0.0001)的哮喘患者使用短效β2激动剂来管理急性哮喘发作,而长效β2激动剂(p = 0.0001)和吸入性糖皮质激素(p = 0.0001)被发现是维持治疗的首选药物。治疗效果(p = 0.004)和成本效益(p = 0.0001)显著作为选择治疗方法的影响因素。大多数患者对其选择的控制哮喘症状的治疗方法感到满意。
大多数哮喘患者在管理急性发作和控制哮喘症状方面更倾向于对抗疗法治疗。发现选择特定治疗方法的主要因素包括有效性、成本和最小副作用。